Heparin-binding protein (HBP), also known as CAP37, is a promising biomarker for predicting the development and prognosis of severe sepsis and septic shock and has recently been proposed to be involved in the pathophysiology of AKI [13,14]. The gene discussed is AZU1; the disease is Sepsis.